Treatment of Hepatitis D - A Future Role for Combination Therapy

N Engl J Med. 2024 Jul 11;391(2):181-183. doi: 10.1056/NEJMe2406180. Epub 2024 Jun 6.

Author

Norah Terrault¹

Affiliation

¹ From the Keck School of Medicine, University of Southern California, Los Angeles.

PMID: 38842503
DOI: 10.1056/NEJMe2406180

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents* / administration & dosage
Antiviral Agents* / adverse effects
Antiviral Agents* / therapeutic use
Clinical Trials as Topic
Disease Eradication
Drug Therapy, Combination
Hepatitis B / drug therapy
Hepatitis D* / drug therapy
Hepatitis D, Chronic / drug therapy
Hepatitis Delta Virus
Humans

Substances

Antiviral Agents
bulevirtide
peginterferon alfa-2a